Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Long

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Experimental Neurology|June 1, 1990
Effects of NMDA receptor antagonists following spinal ischemia in the rabbitA Martinez-Arizala, D D Rigamonti, J B Long, et al.
Brain Research|December 15, 1987
Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanismsJ B Long, R C Kinney, D S Malcolm, et al.
Brain Research|September 11, 1989
Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimineJ B Long, D D Rigamonti, B de Costa, et al.
Neurochemical Research|November 1, 1987
NGF effects on developing forebrain cholinergic neurons are regionally specificM V Johnston, J L Rutkowski, B H Wainer, et al.
European Journal of Pharmacology|August 9, 1988
Hindlimb paralytic effects of prodynorphin-derived peptides following spinal subarachnoid injection in ratsJ B Long, A Martinez-Arizala, E E Echevarria, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injuryJ B Long, D D Rigamonti, M A Oleshansky, et al.
NIDA Research Monograph|January 1, 1986
Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanismsJ B Long, R C Kinney, D S Malcolm, et al.
Brain Research|September 17, 1984
Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesiaJ B Long, P W Kalivas, W W Youngblood, et al.
Peptides|January 12, 2002
In vitro neuroprotection against glutamate-induced toxicity by pGlu-Glu-Pro-NH(2) (EEP)M L Koenig, C M Sgarlat, D L Yourick, et al.
The American Surgeon|September 1, 1986
Selective surgical management of perforated duodenal ulcerS R Klein, J D Wethe, D M Rose, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Experimental Neurology|June 1, 1990
Effects of NMDA receptor antagonists following spinal ischemia in the rabbitA Martinez-Arizala, D D Rigamonti, J B Long, et al.
Brain Research|December 15, 1987
Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanismsJ B Long, R C Kinney, D S Malcolm, et al.
Brain Research|September 11, 1989
Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimineJ B Long, D D Rigamonti, B de Costa, et al.
Neurochemical Research|November 1, 1987
NGF effects on developing forebrain cholinergic neurons are regionally specificM V Johnston, J L Rutkowski, B H Wainer, et al.
European Journal of Pharmacology|August 9, 1988
Hindlimb paralytic effects of prodynorphin-derived peptides following spinal subarachnoid injection in ratsJ B Long, A Martinez-Arizala, E E Echevarria, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injuryJ B Long, D D Rigamonti, M A Oleshansky, et al.
NIDA Research Monograph|January 1, 1986
Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanismsJ B Long, R C Kinney, D S Malcolm, et al.
Brain Research|September 17, 1984
Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesiaJ B Long, P W Kalivas, W W Youngblood, et al.
Peptides|January 12, 2002
In vitro neuroprotection against glutamate-induced toxicity by pGlu-Glu-Pro-NH(2) (EEP)M L Koenig, C M Sgarlat, D L Yourick, et al.
The American Surgeon|September 1, 1986
Selective surgical management of perforated duodenal ulcerS R Klein, J D Wethe, D M Rose, et al.
Pageof 8